ArticleDiagnostics (Basel, Switzerland)2025

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain.

Francesco Gavelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.